| Lightcalls.com |
|
|
![]() |
Considered the oldest healing scien...Considered the oldest healing science in existence, in common scientific study after another, Ayurvedic herbal medicines are proving their tremendous value in protecting mankind from itself -- from the toxic industrialized environment and frenzied societies we have created and their results in turn, on us. Yet there is chance of the desired end A great deal of it. Not single are some ecosystems being sheltered (and restored) and non-frantic lifestyles being adopted, unless ancient wisdom from the dawn of civilization is also being applied to novel medicine, and with some astounding results [ILLUSTRATION OMITTED] What are adaptogens and on what account are they important? According to N Singh, et al., in an article which appeared in the International Journal of immature Drug Research, an adaptogen is any unsalable article or compound, which increases the "SNIR" (state of non-specifically-increased resistance), or NSR (non-specific resistance) to illness/disease-causing factors. Singh informs us that, for a substance to be an adaptogen, it must fitting the following criteria: (a) It should be relatively harmless and cause minimal disruption in the physiological functions of an organism; (b) Its action should be non-specific, increasing resistance to adverse physical, chemical and biological factors; and (c) It must have a normalizing action. I.I. Brekhman and I.V. Dardymov (1969) would add that (d) It should have a wide range of regulatory activity which solitary manifests its action against the actual challenge to the theory (be it a particular disease or disease-causing agent). Ashwagandha, an extract from the radicals and leaves of the plant Withania somnifera (fam. Solanaceae), is just like an adaptogen, with proven drifts in the prevention and treatment of cancer, arthritis, sore s and hypertension, and, in general, preventing the action of psychological and physical stres onward the human organism. Cancer suppression. In 1970 Shohat and colleagues institute that two isolated components of Ashwagandha, Withaferin A and Withanolide E "inhibit (prevent) tumor growth" in Swiss-albino and BDF1 mice, exhibiting a mighty immunosuppressive effect by stopping cancerous confined apartment division in its tracks. More freshly P. Uma Devi and coworkers (1992) attempted to ascertain "the antitumor activity of Ashwagandha parent and to determine an effective put drugs into dose which can be used without serious [] side effects" They establish that administration of an alcohol extract of the plant ended in complete remission of tumor putting out in 25 percent of treated animals and more than 50 percent regression (reversal) of tumor bourgeoning in 63 percent of the animals, and without mortality, and any side powers such as diarrhea or weight loss Anti-inflammation/anti-arthritis. Al-Hindawi, et al. (1989) observ a "significant effect" of Ashwagandha forward the acute inflammatory response in animals. Animals which received the extract revealed a 65 percent inhibition in edema (swelling); it took twice the dose of aspirin to equal this activity. In 1992 Al-Hindawi and colleagues examineed at how well the botanical could cut short inflammation-related effects in treated animals. at day 49, treatment resulted in an 89 percent reduction in arthritic score as compared to those which received no treatment. This was nearly double the validity (44 percent) produced by treatment with hydrocortisone. Anti-ulcer. In 1987 SK Battacharya and coworkers investigated the extract's events in relation to stress-induced gastric sore s They found that daily administration, for a period of four days prior to fester induction, significantly reduced the incidence, total number and severity of pustules formed compared with salt-water-placebo-treated dominion governments Y.P. Sahni and D.N. Srivastava observ similar be deriveds in 1993 in terms of number of imposthumes formed and the severity of those which occurred Ashwagandha, which is typically taken pair times daily in 300 mg doses, has also been shown to be: anti-bacterial (Kazmi, 1991); anti-hypertensive (Ahumada, 1991); learning and memory-enhancing (Kulkarni and Verma, 1992); helpful for symptoms of chronic fatigue (Jayaram, 1993); anti-depressive (Singh, 1989); beneficial for osteoarthritis and rheumatoid arthritis (Kulkarni, 1992); and stimulatory for lactation (Sholapurkar, 1986) COPYRIGHT 1996 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |